Overview

Study of Cetuximab to Treat Gastric Cancer

Status:
Completed

Trial end date:
2009-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of cetuximab combined with FOLFIRI in patients with advanced gastric cancer who failed first-line chemotherapy

Phase:

Phase 2

Details

Lead Sponsor:

Fudan University

Treatments:

Cetuximab